C16 Biosciences Stock
C16 Biosciences produces Palmless™, a sustainable, biodesigned alternative to palm oil, addressing deforestation and environmental harm caused by traditional palm oil production. The company's proprietary biomanufacturing platform delivers high-performance, eco-friendly oils for beauty, personal care, and food industries.
Founded: 2018
C16 Biosciences Company Overview
Management Team
| Shara Ticku Co-Founder & Chief Executive Officer |
| David Heller Co-Founder & Chief Operating Officer |
| Stephen Picataggio Ph.D Chief Scientific Officer |
| Harold McNamara Co-Founder |
Funding Information
News
News
Department of Defense funds fermentation projects
The US Department of Defense has selected 12 more companies for funding through its Distributed Bioindustrial Manufacturing Program. All the firms are using fermentation to make chemicals and fuels. The awardees—Air Protein, Algenesis, Bluestem Biosciences, C16 Biosciences, Cellibre, Danimer Scientific, Erg Bio, ETSU Research, Fermworx, Mussel Polymers, Onego Bio, and Savor Foods—will each receive up to $2 million to develop detailed plans for commercial-scale biomanufacturing plants. Resulting designs will be eligible for up to $100 million in implementation funds. The White House says it expects 30 total projects to receive funding.
The World's Most Innovative Companies of 2024
Fast Company's annual ranking of the World's Most Innovative Companies covers 58 industries and sectors, from advertising to video.
C16 Biosciences, makers of Palmless™, ramps up in food fueled by fresh funding
NEW YORK, January 24, 2024--C16 Biosciences, makers of Palmless™, the platform for sustainable palm oil alternatives, is ramping up its capabilities in the food category, fueled by a $3.5 million grant from the Bill & Melinda Gates Foundation as well as a $1 million investment from Elemental Excelerator.